JOSEPH CHARLES: Open Payments
NPI 1245309624 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 12 payments from 5 companies in 2025. Trend: 2023 $389 · 2024 $884 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $286 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| ABBVIE INC. | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: LYBALVI, Auvelity, VIVITROL, VRAYLAR, HETLIOZ, ARISTADA, CAPLYTA.
Industry payments across NY — which companies pay providers there.
